WallStSmart
NRC

National Research Corp

NASDAQ: NRC · HEALTHCARE · HEALTH INFORMATION SERVICES

$18.71
+3.73% today

Updated 2026-06-04

Market cap
$431.35M
P/E ratio
49.08
P/S ratio
3.11x
EPS (TTM)
$0.39
Dividend yield
2.84%
52W range
$11 – $23
Volume
0.1M

National Research Corp (NRC) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$43.77M$48.92M$51.01M$57.69M$63.40M$75.77M$86.42M$92.59M$98.84M$102.34M$109.38M$117.56M$119.69M$127.98M$133.28M$147.95M$151.57M$148.58M$143.06M$137.39M
Revenue growth (YoY)+11.8%+4.3%+13.1%+9.9%+19.5%+14.1%+7.1%+6.7%+3.5%+6.9%+7.5%+1.8%+6.9%+4.1%+11.0%+2.4%-2.0%-3.7%-4.0%
Cost of revenue$19.45M$21.80M$23.61M$24.57M$24.64M$28.67M$35.46M$38.84M$41.72M$44.61M$45.58M$49.07M$47.58M$46.44M$49.19M$52.35M$57.05M$56.02M$56.93M$59.99M
Gross profit$24.33M$27.12M$27.40M$33.12M$38.76M$47.10M$50.96M$53.75M$57.12M$57.73M$63.81M$68.49M$72.11M$81.55M$84.09M$95.60M$94.52M$92.56M$86.13M$77.39M
Gross margin55.6%55.4%53.7%57.4%61.1%62.2%59.0%58.0%57.8%56.4%58.3%58.3%60.2%63.7%63.1%64.6%62.4%62.3%60.2%56.3%
R&D$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
SG&A$12.16M$13.17M$12.73M$15.59M$20.20M$23.30M$23.54M$25.21M$25.02M$27.18M$28.39M$29.69M$31.37M$32.97M$34.44M$38.96M$42.70M$46.09M$44.91M$54.80M
Operating income$9.91M$11.37M$11.99M$13.70M$13.86M$18.73M$22.72M$24.81M$28.30M$26.45M$31.20M$34.22M$35.27M$43.03M$42.68M$50.27M$46.54M$40.05M$35.19M$22.59M
Operating margin22.6%23.2%23.5%23.7%21.9%24.7%26.3%26.8%28.6%25.8%28.5%29.1%29.5%33.6%32.0%34.0%30.7%27.0%24.6%16.4%
EBITDA$12.17M$13.95M$14.72M$17.35M$18.51M$23.85M$27.45M$28.62M$32.20M$31.69M$35.77M$38.95M$41.69M$48.57M$50.78M$56.66M$49.30M$45.98M$41.31M$30.23M
EBITDA margin27.8%28.5%28.8%30.1%29.2%31.5%31.8%30.9%32.6%31.0%32.7%33.1%34.8%38.0%38.1%38.3%32.5%30.9%28.9%22.0%
EBIT$9.91M$11.37M$12.03M$13.52M$13.81M$18.79M$22.75M$24.89M$28.40M$27.58M$31.55M$34.37M$36.22M$43.03M$43.28M$50.29M$44.02M$40.09M$35.28M$22.61M
Interest expense$0.00$0.00$139000.00$405000.00$491000.00$629000.00$541000.00$397000.00$305000.00$220000.00$190000.00$82000.00$1.51M$2.09M$1.81M$1.67M$1.21M$862000.00$2.60M$4.76M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$5.88M$6.84M$7.45M$8.49M$8.50M$11.56M$15.07M$15.48M$18.16M$17.61M$20.52M$22.94M$30.05M$32.41M$37.26M$37.47M$31.80M$30.97M$24.78M$11.60M
Net income growth (YoY)+16.2%+8.9%+14.0%+0.1%+36.1%+30.3%+2.8%+17.3%-3.0%+16.5%+11.8%+31.0%+7.9%+15.0%+0.6%-15.1%-2.6%-20.0%-53.2%
Profit margin13.4%14.0%14.6%14.7%13.4%15.3%17.4%16.7%18.4%17.2%18.8%19.5%25.1%25.3%28.0%25.3%21.0%20.8%17.3%8.4%

Frequently asked questions

What is National Research Corp's revenue?

National Research Corp's trailing twelve-month revenue is $138.64M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is NRC?

In its most recent fiscal year, NRC ran a gross margin of 56.33%, an operating margin of 16.44%, and a net margin of 8.44%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does NRC generate?

NRC produced $15.74M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is NRC's balance sheet healthy?

NRC holds $4.14M in cash and equivalents against $75.02M in long-term debt, on $13.99M of shareholder equity. That debt is best read against the cash flow the business throws off each year.